MAPLIGHT THERAPEUTICS APPOINTS TIM GARNETT, M.D. TO BOARD OF DIRECTORS

Industry Leader Appointed to MapLight’s Board of Directors SAN FRANCISCO, July 24, 2023 /PRNewswire/ — MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of people with brain disorders, today announced…

Click here to view original post